Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report) Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report)

Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report‪)‬

Clinical Chemistry 2005, Jan, 51, 1

    • €2.99
    • €2.99

Publisher Description

Ideally, blood samples for biomarker measurement are collected centrally and processed immediately to avoid any unwanted changes in concentrations that could affect validity. In large-scale epidemiologic and clinical studies, however, this theoretical goal must give way to a more pragmatic approach (1, 2). The Amsterdam Born Children and their Development (ABCD) study is a clinically based cohort study of pregnant women in Amsterdam (The Netherlands) in which we use, for practical and ethical reasons, blood collection in conjunction with existing schemes of care, with samples subsequently sent to a central laboratory by mail or courier. As a consequence, delay times between collection and processing may exceed 24 h, to an incidental maximum of 96 h. Although the stabilities of the biomarkers of interest, i.e., C-reactive protein (CRP), retinol, ferritin, folic acid, and fatty acids (FAs), have been studied previously (1-9), the variety of designs (e.g., storage [less than or equal to] 24 h) hampers the applicability of existing results to our research and similar studies. We therefore investigated the appropriateness of our standardized, practice-based approach of blood collection by assessing stability in samples stored up to 96 h (the maximum delay time possible when samples are sent by mail) with a focus on the first 28 h (the maximum delay time allowed in the ABCD study). Blood samples were collected from 41 generally healthy female volunteers, 22-56 years of age. One woman was at that time 16 weeks pregnant, but because her measurements did not deviate, we decided not to exclude her from analysis. Written informed consent was obtained from all participants. For 20 women, 28 mL of blood was collected in seven 4-mL Vacuettes (Greiner BV) for the preparation of serum. For the other 21 women, 28 mL of blood was collected in seven 4-mL Vacutainer EDTA tubes (Becton and Dickinson BV) for the preparation of plasma. One tube from each woman was centrifuged (1600g for 10 min) between 1 and 2 h after blood collection (to; baseline), and the remaining tubes were stored in a cabinet at room temperature (~21[degrees]C) and centrifuged 2 ([t.sub.2]), 4 ([t.sub.4]), 24 ([t.sub.24]), 26 ([t.sub.26]), 28 ([t.sub.28]), or 96 ([t.sub.96]) h after baseline. Time points were chosen to mimic courier and postal conditions seen in the ABCD study, 4 h being the anticipated maximum delay time when blood is sent by courier, 28 h being the anticipated maximum delay time when blood is sent by overnight mail, and 96 h being the anticipated maximum delay time when blood is sent by mail but over the weekend.

GENRE
Science & Nature
RELEASED
2005
1 January
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
315.7
KB
Can Heparin Plasma Be Used Instead of Serum for Nephelometric Analysis of Serum Proteins?(Letters) (Letter to the Editor) Can Heparin Plasma Be Used Instead of Serum for Nephelometric Analysis of Serum Proteins?(Letters) (Letter to the Editor)
2006
Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys (General Clinical Chemistry) Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys (General Clinical Chemistry)
2002
Immunoradiometric Assay of Circulating C-Reactive Protein: Age-Related Values in the Adult General Population (Enzymes and Protein Markers) Immunoradiometric Assay of Circulating C-Reactive Protein: Age-Related Values in the Adult General Population (Enzymes and Protein Markers)
2000
Effect of Vitamin E Supplementation with Standard Treatment on Oxidant-Antioxidant Status in Chronic Obstructive Pulmonary Disease (Report) Effect of Vitamin E Supplementation with Standard Treatment on Oxidant-Antioxidant Status in Chronic Obstructive Pulmonary Disease (Report)
2008
Fundamentals of Analytical Toxicology Fundamentals of Analytical Toxicology
2020
Metabolomics in Practice Metabolomics in Practice
2013
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003